Physician profile
Benjamin J Brill
NPI 1609202555
$23,269.01
in general payments reported to CMS, 2019-2025
15 companies · $430 in 2025
The $430 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,237 · 2020: $6,373 · 2021: $9,988 · 2022: $155 · 2023: $202 · 2024: $883 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917 · Travel and Lodging: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.08 |
| Travel and Lodging | $598.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $8,737.26 | 2020-2021 | |
| Arthrex, INC. | $7,261.71 | 2019-2020 | |
| Kairos Surgical INC | $3,711.57 | 2019-2021 | |
| Prodigy Surgical Distribution, INC. | $1,225.08 | 2021 | |
| Encore Medical, LP | $646.34 | 2024 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $613.84 | 2019-2025 | Comprehensive |
| Stryker Corporation | $450.00 | 2019-2024 | Mako, Triathlon, Gamma |
| Miach Orthopaedics, INC. | $184.34 | 2025 | |
| Medical Device Business Services, INC. | $135.99 | 2019-2025 | Inhance, Velys |
| Depuy Synthes Sales INC. | $115.50 | 2023 | |
| Bioventus LLC | $91.08 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $31.37 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $27.59 | 2025 | |
| Djo, LLC | $20.90 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Brill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.